Tech Company Financing Transactions

FoldRx Pharmaceuticals Funding Round

FoldRx Pharmaceuticals, based in Cambridge, secured $32.3 million in investment from Alta Partners, F-Prime Capital and HealthCare Ventures.

Transaction Overview

Announced On
3/31/2007
Transaction Type
Venture Equity
Amount
$32,251,300
Round
Undisclosed
Investors

Alta Partners (Ed Hurwitz)

F-Prime Capital (Stephen Knight)

HealthCare Ventures (Augustine Lawlor)

Novartis BioVenture Fund

TPG Capital (Geoffrey Duyk)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
100 Acorn Park Drive 5th Floor
Cambridge, MA 02140
USA
Email Address
Overview
FoldRx is a leader in the discovery and development of first in class disease modifying drug therapies for diseases of protein misfolding and amyloidosis.
Profile
FoldRx Pharmaceuticals LinkedIn Company Profile
Social Media
FoldRx Pharmaceuticals Company Twitter Account
Company News
FoldRx Pharmaceuticals News
Facebook
FoldRx Pharmaceuticals on Facebook
YouTube
FoldRx Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Richard Labaudiniere
  Richard Labaudiniere LinkedIn Profile  Richard Labaudiniere Twitter Account  Richard Labaudiniere News  Richard Labaudiniere on Facebook
Chief Medical Officer
Donna Grogan
  Donna Grogan LinkedIn Profile  Donna Grogan Twitter Account  Donna Grogan News  Donna Grogan on Facebook
Vice President
Bill Aliski
  Bill Aliski LinkedIn Profile  Bill Aliski Twitter Account  Bill Aliski News  Bill Aliski on Facebook
Vice President
Jeff Packman
  Jeff Packman LinkedIn Profile  Jeff Packman Twitter Account  Jeff Packman News  Jeff Packman on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2007: AuthenTec venture capital transaction
Next: 3/31/2007: ReGen Biologics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary